Research

Displaying 81 - 90 of 208


Study examines HIV drug’s potential to treat Alzheimer’s

A drug used to treat and prevent HIV/AIDS is showing promise as a potential therapy for Alzheimer’s disease, and Vanderbilt University biochemist F. Peter Guengerich, PhD, is aiding efforts to make this approach to improving memory and cognitive function even better.


LAPOP Receives $10 Million USAID Grant to Support AmericasBarometer Survey

Vanderbilt’s LAPOP lab for international survey research has received a $10 million, five-year U.S. Agency for International Development (USAID) grant to support its influential AmericasBarometer survey and related activities.


Simaan honored as IEEE Fellow for robotics advancements

Nabil Simaan, professor of mechanical engineering, has been elevated to IEEE Fellow by the Board of Directors of the Institute of Electrical and Electronics Engineers.


Anita Mahadevan-Jansen elected National Academy of Inventors Fellow

Anita Mahadevan-Jansen, Orrin H. Ingram Professor of Engineering and director of the Vanderbilt Biophotonics Center, has been elected as a fellow of the National Academy of Inventors, the highest professional distinction accorded solely to academic inventors.


Project seeks new way to assess immunotherapy effectiveness

GE Healthcare has awarded researchers in the Vanderbilt University Institute of Imaging Science (VUIIS) $2.5 million in funding to develop a positron emission tomography (PET) tracer that will determine the effectiveness of immunotherapy in patients early in their treatment course.


Endotoxin shock protector

Using a novel cell-penetrating peptide they designed and tested in mice that selectively suppresses nuclear transport through importin alpha 5, Jacek Hawiger, MD, PhD, Jozef Zienkiewicz, PhD, Yan Liu, MD, and colleagues showed that endotoxin shock is mediated by proinflammatory SRTFs rather than lipid-regulating SREBPs.